Syndax Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Syndax Pharmaceuticals patents 6 in total

Status Patent
Grant
Utility: Selection of patients for combination therapy External link
Filling date: 6 Sep 2025 Issue date: 26 Jul 2022
Grant
Utility: Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer External link
Filling date: 6 Sep 2025 Issue date: 10 May 2022
Application
Utility: SELECTION OF PATIENTS FOR COMBINATION THERAPY External link
Filling date: 6 Sep 2025 Issue date: 5 Aug 2021
Application
Utility: COMBINATION THERAPIES External link
Filling date: 6 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: METHODS FOR THE TREATMENT OF BREAST CANCER External link
Filling date: 6 Sep 2025 Issue date: 14 Nov 2019
Application
Utility: COMBINATION OF HDAC INHIBITOR AND ANTI-PD-L1 ANTIBODY FOR TREATMENT OF OVARIAN CANCER External link
Filling date: 6 Sep 2025 Issue date: 26 Sep 2019

Showing 1 to 6 of 6 patents.